Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMPBA0D)

Drug Name

Sofpironium bromide Drug Info

Synonyms

BBI-4000; 1628106-94-4; Sofpironium bromide [USAN]; CHEMBL3707223; Sofpironium bromide (JAN/USAN/INN); D10989; Pyrrolidinium, 3-(((2R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy)-1-(2-ethoxy-2-oxoethyl)-1-methyl-, bromide (1:1), (3R)-

Indication

Disease Entry	ICD 11	Status	REF
Primary axillary hyperhidrosis	EE00.01	Phase 3	[1]

Cross-matching ID

PubChem CID: 86301316
CAS Number: CAS 1628106-94-4
TTD Drug ID: DMPBA0D

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Cholinergic receptor unspecific (CHR)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Cisatracurium	DMUZPJ5	Muscle spasm	MB47.3	Approved	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cholinergic receptor unspecific (CHR)	TTUPDWN	NOUNIPROTAC	Antagonist	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03627468) A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3	Bradycardia produced by pyridostigmine and physostigmine. Can J Anaesth. 1997 Dec;44(12):1286-92.